Literature DB >> 20173259

Disparities associated with advanced prostate cancer stage at diagnosis.

Nicole M Marlow1, Michael T Halpern, Alexandre L Pavluck, Elizabeth M Ward, Amy Y Chen.   

Abstract

This study expands on a previous report (focusing on health insurance status and race/ethnicity) to present effects of age, socioeconomic status, hospital type, and other factors (e.g., type of Medicaid and Medicare coverage, insurance-by-race/ethnicity interactions) on advanced-stage (III/IV) at prostate cancer diagnosis. Invasive (Stages I-IV) prostate cancer cases diagnosed during 1998-2004 were extracted from the National Cancer Database (N=687,464). Independent of health-insurance and race/ethnicity, socioeconomic status was a significant predictor of advanced stage at diagnosis, with patients residing in areas with lower socioeconomic characteristics having significantly increased odds. Those treated at community-cancer-centers had significantly decreased odds (versus teaching/research-facilities). Significantly increased odds were also observed among uninsured-Blacks, Medicare-insured-Blacks, Medicaid-insured-Blacks, Medicare-insured-Hispanics, and Medicare-insured-other-racial/ethnic-minorities 65 years old and older (versus corresponding White-populations). The impact of prostate cancer screening on reducing mortality remains debatable. Still, our results suggest improvements in multiple factors that affect access-to-care may achieve earlier diagnosis and, therefore, a potentially more treatable disease.

Entities:  

Mesh:

Year:  2010        PMID: 20173259     DOI: 10.1353/hpu.0.0253

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  18 in total

1.  African-American and Caribbean-Born Men's Perceptions of Prostate Cancer Fear and Facilitators for Screening Behavior: a Pilot Study.

Authors:  Ewan K Cobran; Jori N Hall; William D Aiken
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

2.  Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts
Journal:  J Health Care Poor Underserved       Date:  2011

3.  Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.

Authors:  Benjamin J Miller; Peter Cram; Charles F Lynch; Joseph A Buckwalter
Journal:  J Bone Joint Surg Am       Date:  2013-07-03       Impact factor: 5.284

4.  Primary care physician supply, insurance type, and late-stage cancer diagnosis.

Authors:  Jesse J Plascak; James L Fisher; Electra D Paskett
Journal:  Am J Prev Med       Date:  2014-10-29       Impact factor: 5.043

5.  Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Georges Adunlin; Askal Ayalew Ali; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2014-12-26

6.  Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.

Authors:  Elizabeth D Kantor; Loren Lipworth; Jay H Fowke; Edward L Giovannucci; Lorelei A Mucci; Lisa B Signorello
Journal:  Prostate       Date:  2015-05-27       Impact factor: 4.104

7.  Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.

Authors:  Mariana Chavez-MacGregor; Joseph M Unger; Anna Moseley; Scott D Ramsey; Dawn L Hershman
Journal:  Cancer       Date:  2018-01-25       Impact factor: 6.860

8.  Building Capacity in a Rural North Carolina Community to Address Prostate Health Using a Lay Health Advisor Model.

Authors:  Anissa I Vines; Jaimie C Hunter; Brandolyn S White; Alan N Richmond
Journal:  Health Promot Pract       Date:  2015-07-31

9.  Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes.

Authors:  Matthew A Kinseth; Zhenyu Jia; Farahnaz Rahmatpanah; Anne Sawyers; Manuel Sutton; Jessica Wang-Rodriguez; Dan Mercola; Kathleen L McGuire
Journal:  Int J Cancer       Date:  2013-07-13       Impact factor: 7.396

10.  Robotic prostatectomy is associated with increased patient travel and treatment delay.

Authors:  Matthew J Maurice; Hui Zhu; Simon P Kim; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2016 May-Jun       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.